eso logo

safe logo

References

  1. http://www.un.org/en/development/desa/population/publications/pdf/ageing/WPA2017_Highlights.pdf
  2. Aboderin I, Venables G and Asplund K. Stroke management in Europe. J Intern Med 1996; 240: 173–180.
  3. Kjellström T, Norrving B and Shatchkute A. Helsingborg Declaration 2006 on European Stroke Strategies. Cerebrovasc Dis 2007; 23: 229–241.
  4. O'Donnell MJ, Chin SL, Rangarajan S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet 2016; 388: 761‒775.
  5. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016; 37: 2315‒2381.
  6. Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129(25 Suppl 2): S49‒S73.
  7. GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390: 1345‒1422.
  8. Stevens E, McKevitt C, Emmett E, et al. The burden of stroke in Europe. London: Stroke Alliance for Europe (SAFE), 2017. Available at: http://www.strokeeurope.eu/downloads/TheBurdenOfStrokeInEuropeReport.pdf Accessed 19 April 2018.
  9. https://www.escardio.org/Education/Practice-Tools/CVD-prevention-toolbox/SCORE-Risk-Charts
  10. Beishuizen CR, Stephan BC, van Gool WA, et al. Web-based interventions targeting cardiovascular risk factors in middle-aged and older people: a systematic review and meta-analysis. J Med Internet Res 2016; 18(3): e55.
  11. Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed) 1981; 282: 1847‒1851.
  12. World Health Organization. HO – Global action plan for the prevention and control of non-communicable diseases 2013-2020. Available at:
    http://africahealthforum.afro.who.int/IMG/pdf/global_action_plan_for_the_prevention_and_control_of_ncds_2013-2020.pdf  Accessed 4 May 2018.
  13. Kotseva K, Wood D, De Backer G, et al. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries. Eur J Cardiovasc Prev Rehabil 2010; 17: 530‒540.
  14. WHO - http://apps.who.int/iris/bitstream/10665/156262/1/9789241564922_eng.pdf?ua=1
  15. www.ec.europa/eurostat
  16. Lewey J, Shrank WH, Bowry AD, et al. Gender and racial disparities in adherence to statin therapy: a meta-analysis. Am Heart J 2013; 165: 665‒678.
  17. Freedman B, Camm J, Calkins H, et al. Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration. Circulation 2017; 135: 1851‒1867.
  18. Waje-Andreassen U, Nabavi DG, Engelter ST, et al. European Stroke Organisation certification of stroke units and stroke centres. Eur Stroke J 2018; [ePub ahead of print]
  19. Hillmann S, Wiedmann S, Fraser A, et al. Temporal changes in the quality of acute stroke care in five national audits across Europe. Biomed Res Int 2015; 2015: 432497.
  20. Mellon L, Hickey A, Doyle F, et al. Can a media campaign change health service use in a population with stroke symptoms? Examination of the first Irish stroke awareness campaign. Emerg Med J 2014; 31: 536‒540.
  21. Cadilhac DA, Kim J, Lannin NA, et al. National stroke registries for monitoring and improving the quality of hospital care: A systematic review. Int J Stroke 2016; 11: 28‒40.
  22. Wellwood I, Wu O, Langhorne P, et al. Developing a tool to assess quality of stroke care across European populations: the EROS Quality Assessment Tool. Stroke 2011; 42: 1207‒1211.
  23. Rudd M, Buck D, Ford GA, et al. A systematic review of stroke recognition instruments in hospital and prehospital settings. Emerg Med J 2016; 33: 818‒822.
  24. Watkins CL, Leathley MJ, Jones SP, et al. Training emergency services' dispatchers to recognise stroke: an interrupted time-series analysis. BMC Health Serv Res 2013; 13: 318.
  25. Fothergill RT, Williams J, Edwards MJ, et al. Does use of the recognition of stroke in the emergency room stroke assessment tool enhance stroke recognition by ambulance clinicians? Stroke 2013; 44: 3007‒3012.
  26. Eriksson M, Glader EL, Norrving B, et al.Acute stroke alert activation, emergency service use, and reperfusion therapy in Sweden. Brain Behav 2017; 7(4): e00654.
  27. Faiz KW, Sundseth A, Thommessen B, et al. Prehospital delay in acute stroke and TIA. Emerg Med J 2013; 30: 669‒674.
  28. Ebinger M, Kunz A, Wendt M, et al. Effects of golden hour thrombolysis: a Prehospital Acute Neurological Treatment and Optimization of Medical Care in Stroke (PHANTOM-S) substudy. JAMA Neurol 2015; 72: 25‒30.
  29. Reiner-Deitemyer V, Teuschl Y, Matz K, et al. Helicopter transport of stroke patients and its influence on thrombolysis rates: data from the Austrian Stroke Unit Registry. Stroke 2011; 42: 1295‒1300.
  30. Lahr MM, Luijckx GJ, Vroomen PC, et al. Proportion of patients treated with thrombolysis in a centralized versus a decentralized acute stroke care setting. Stroke 2012; 43: 1336‒1340.
  31. Bray BD, Ayis S, Campbell J, et al. Associations between the organisation of stroke services, process of care, and mortality in England: prospective cohort study. BMJ 2013; 346: f2827.
  32. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2013; 9: CD000197.
  33. Wardlaw JM, Seymour J, Cairns J, et al. Immediate CT scanning of acute stroke is cost effective and improves quality of life. Stroke 2004; 35: 2477‒2483.
  34. Fearon P, Langhorne P, Early Supported Discharge Trialists. Services for reducing duration of hospital care for acute stroke patients. Cochrane Database Syst Rev 2012; 9: CD000443.
  35. Langhorne P, Baylan S, Early Supported Discharge Trialists. Early supported discharge services for people with acute stroke. Cochrane Database Syst Rev 2017; 7: CD000443.
  36. Audebert HJ, Schultes K, Tietz V, et al. Long-term effects of specialized stroke care with telemedicine support in community hospitals on behalf of the Telemedical Project for Integrative Stroke Care (TEMPiS). Stroke 2009; 40: 902‒908.
  37. Urimubenshi G, Langhorne P,Cadilhac DA, et al. Association between patient outcomes and key performance indicators of stroke care quality: A systematic review and meta-analysis. Eur Stroke J 2017; 2: 287–307.
  38. Bray BD, Cloud GC, James MA, et al. Weekly variation in health-care quality by day and time of admission: a nationwide, registry-based, prospective cohort study of acute stroke care. Lancet 2016; 388: 170‒177.
  39. Bray BD, Campbell J, Cloud GC, et al. Bigger, faster? Associations between hospital thrombolysis volume and speed of thrombolysis administration in acute ischemic stroke. Stroke 2013; 44: 3129‒3135.
  40. Fischer U, et al. Access to and delivery of acute ischaemic stroke treatments: a survey of national scientific societies and stroke experts in 44 European countries. Eur Stroke J 2018; in press.
  41. Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375: 1695‒1703.
  42. Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014; 384: 1929‒1935.
  43. Saver JL, Goyal M, van der Lugt A, et al. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA 2016; 316: 1279‒1288.
  44. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2013; 9: CD000197.
  45. Reinink H, de Jonge JC, Bath PM, et al. PRECIOUS: PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke. Rationale and design of a randomised, open, phase III, clinical trial with blinded outcome assessment. Eur Stroke J 2018; in press.
  46. Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med 2018 May 16 [Epub ahead of print].
  47. Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372: 11–20.
  48. Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015; 372: 1019–30.
  49. Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015; 372: 2285–95.
  50. Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015; 372: 1009–18.
  51. Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015; 372: 2296–306.
  52. Thomalla G, Simonsen CZ, Boutitie F, et al. MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med 2018 May 16. doi: 10.1056/NEJMoa1804355. [Epub ahead of print]
  53. Steiner T, Al-Shahi Salman R, Beer R, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke 2014; 9: 840‒855.
  54. Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2015; 46: 2032‒2060.
  55. Steiner T, Juvela S, Unterberg A, et al. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis 2013; 35: 93‒112.
  56. Connolly ES Jr, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke 2012; 43: 1711‒1737.
  57. Geurts M, Macleod MR, van Thiel GJ, et al. End-of-life decisions in patients with severe acute brain injury. Lancet Neurol 2014; 13: 515-24.
  58. Lawrence M, Pringle J, Kerr S, et al. Multimodal secondary prevention behavioral interventions for TIA and stroke: a systematic review and meta-analysis. PLoS One 2015; 10: e0120902.
  59. Deijle IA, Van Schaik SM, Van Wegen EE, et al. Lifestyle interventions to prevent cardiovascular events after stroke and transient ischemic attack: systematic review and meta-analysis. Stroke 2017; 48: 174‒179.
  60. D'Isabella NT, Shkredova DA, Richardson JA, et al. Effects of exercise on cardiovascular risk factors following stroke or transient ischemic attack: a systematic review and meta-analysis. Clin Rehabil 2017; 31: 1561‒1572.
  61. Katsanos AH, Filippatou A, Manios E, et al. Blood pressure reduction and secondary stroke prevention: a systematic review and metaregression analysis of randomized clinical trials. Hypertension 2017; 69: 171‒179.
  62. Niu PP, Guo ZN, Jin H, et al. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis. BMJ Open 2016; 6: e009013.
  63. Koskinas KC, Siontis GCM, Piccolo R, et al. Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials. Eur Heart J 2018; 39: 1172‒1180.
  64. Lokuge K, de Waard DD, Halliday A, et al. Meta-analysis of the procedural risks of carotid endarterectomy and carotid artery stenting over time. Br J Surg 2018; 105: 26‒36.
  65. López-López JA, Sterne JAC, Thom HHZ, et al. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis. BMJ 2017; 359: j5058.
  66. Niu X, Ou-Yang G, Yan PF, et al. Closure of patent foramen ovale for cryptogenic stroke patients: an updated systematic review and meta-analysis of randomized trials. J Neurol 2018 January 30 [Epub ahead of print]
  67. World Health Organization. World Report on Disability 2011. Geneva: World Health Organization; 2011. 4, Rehabilitation. Available from: https://www.ncbi.nlm.nih.gov/books/NBK304081/ Accessed 19 April 2018.
  68. United Nations Division for Social Policy and Development. Convention on the Rights of Persons with Disabilities (CRPD). Available at: https://www.un.org/development/desa/disabilities/convention-on-the-rights-of-persons-with-disabilities.html. Accessed 19 April 2018.
  69. World Health Organization. Rehabilitation 2030: A Call for Action. February 2017. Available at: http://www.who.int/disabilities/care/rehab-2030/en/ Accessed 24 April 2018.
  70. Forster A, Brown L, Smith J, et al. Information provision for stroke patients and their caregivers. Cochrane Database Syst Rev 2012; 11: CD001919.
  71. Brady MC, Kelly H, Godwin J, et al. Speech and language therapy for aphasia following stroke. Cochrane Database Syst Rev 2016; 6: CD000425.
  72. Legg LA, Lewis SR, Schofield-Robinson OJ, et al. Occupational therapy for adults with problems in activities of daily living after stroke. Cochrane Database Syst Rev 2017; 7: CD003585.
  73. Saunders DH, Sanderson M, Hayes S, et al. Physical fitness training for stroke patients. Cochrane Database Syst Rev 2016; 3: CD003316.
  74. English C, Hillier SL, Lynch EA. Circuit class therapy for improving mobility after stroke. Cochrane Database Syst Rev 2017; 6: CD007513.
  75. Vienneau D, de Hoogh K, Faeh D, et al. More than clean air and tranquillity: Residential green is independently associated with decreasing mortality. Environ Int 2017; 108: 176‒184.
  76. de Gelder R, Koster EM, van Buren LP, et al. Differences in adults' health and health behaviour between 16 European urban areas and the associations with socio-economic status and physical and social environment. Eur J Public Health 2017; 27(suppl 2): 93‒99.
  77. Aziz NA, Leonardi-Bee J, Phillips M, et al. Therapy-based rehabilitation services for patients living at home more than one year after stroke. Cochrane Database Syst Rev 2008 ;2: CD005952.
  78. Pollock A, Baer G, Campbell P, et al. Physical rehabilitation approaches for the recovery of function and mobility following stroke. Cochrane Database Syst Rev 2014; 4: CD001920.
  79. Mehrholz J, Thomas S, Elsner B. Treadmill training and body weight support for walking after stroke. Cochrane Database Syst Rev 2017; 8: CD002840.
  80. Mehrholz J, Pohl M, Platz T, et al. Electromechanical and robot-assisted arm training for improving activities of daily living, arm function, and arm muscle strength after stroke. Cochrane Database Syst Rev 2015; 11: CD006876.
  81. Morris R. Meeting the psychological needs of community-living stroke patients and carers: a study of third sector provision. Disabil Rehabil 2016; 38: 52‒61.
  82. Turner-Stokes L, Pick A, Nair A, et al. Multi-disciplinary rehabilitation for acquired brain injury in adults of working age. Cochrane Database Syst Rev 2015; 12: CD004170.
  83. European Stroke Oranisation. Guidelines directory. Available at: https://eso-stroke.org/eso-guideline-directory Accessed 1 May 2018.
  84. Norrving B, Bray BD, Asplund K, et al. Cross-national key performance measures of the quality of acute stroke care in Western Europe. Stroke 2015; 46: 2891‒2895.
  85. Aziz NA, Pindus DM, Mullis R, et al. Understanding stroke survivors' and informal carers' experiences of and need for primary care and community health services--a systematic review of the qualitative literature: protocol. BMJ Open 2016; 6: e009244.
  86. Sacco RL, Sandercock P, Endres M, et al. Review and prioritization of stroke research recommendations to address the mission of the World Stroke Organization: a call to action from the WSO Research Committee. Int J Stroke 2015; 10(Suppl A100): 4‒9.
  87. World Stroke Organisation. Global Stroke Bill of Rights. Available at: www.worldstrokecampaign.org/images/global_stroke_bill_of_rights/English_GlobalBORights_web.pdf
  88. McKevitt C, Fudge N, Redfern J, et al. Self-reported long-term needs after stroke. Stroke 2011; 42: 1398‒1403.
  89. Murray J, Young J, Forster A, et al. Feasibility study of a primary care-based model for stroke aftercare. Br J Gen Pract 2006; 56: 775‒780.
  90. Daniel K, Wolfe CD, Busch MA, et al. What are the social consequences of stroke for working-aged adults? A systematic review. Stroke 2009; 40: e431‒e440.
  91. Stroke Association. Feeling Overwhelmed: The emotional impact of stroke. Available at: https://www.stroke.org.uk/sites/default/files/feeling_overwhelmed_final_web_0.pdf
  92. Department of Health. National Stroke Stategy, December 2007. Available at: http://www.clahrc-gm.nihr.ac.uk/wp-content/uploads/DoH-National-Stroke-Strategy-2007.pdf
  93. Pindus DM, Mullis R, Lim L, et al. Stroke survivors' and informal caregivers' experiences of primary care and community healthcare services - A systematic review and meta-ethnography. PLoS One 2018; 13: e0192533.
  94. Katzan IL, Thompson NR, Lapin B, et al. Added value of patient-reported outcome measures in stroke clinical practice. J Am Heart Assoc 2017; 6: e005356.
  95. Riksstroke. Brief summary of data for the full year 2016. available at: http://www.riksstroke.org/wp-content/uploads/2017/11/Brief-summary-of-Riksstroke-data-for-the-full-year-2016.pdf
  96. Nilsson E, Orwelius L, Kristenson M. Patient-reported outcomes in the Swedish National Quality Registers. J Intern Med 2016; 279: 141‒153.
  97. Demuth HU, Dijkhuizen RM, Farr TD, et al. Recent progress in translational research on neurovascular and neurodegenerative disorders. Restor Neurol Neurosci 2017; 35: 87‒103.
  98. Bosetti F, Koenig JI, Ayata C, et al. Translational stroke research: vision and opportunities. Stroke 2017; 48: 2632‒2637.
  99. Smart N, Pries AR, Dirnagl U. Dr Smart talks to Prof Pries and Prof Dirnagl on animal experimentation in biomedical research. Cardiovasc Res 2017; 113: e12‒e15.
  100. Neuhaus AA, Couch Y, Hadley G, et al. Neuroprotection in stroke: the importance of collaboration and reproducibility. Brain 2017; 140: 2079‒2092.
  101. De Meyer SF, Denorme F, Langhauser F, et al. Thromboinflammation in stroke brain damage. Stroke 2016; 47: 1165‒1172.
  102. Savitz SI, Baron JC, Yenari MA, et al. Reconsidering neuroprotection in the reperfusion era. Stroke 2017; 48: 3413‒3419.
  103. Anrather J, Iadecola C. Inflammation and stroke: an overview. Neurotherapeutics 2016; 13: 661‒670.
  104. Walker KA, Power MC, Hoogeveen RC, et al. Midlife systemic inflammation, late-life white matter integrity, and cerebral small vessel disease: the Atherosclerosis Risk in Communities Study. Stroke 2017; 48: 3196‒3202.
  105. Yu IC, Kuo PC, Yen JH, Paraiso HC, Curfman ET, Hong-Goka BC, Sweazey RD, Chang FL. A combination of three repurposed drugs administered at reperfusion as a promising therapy for postischemic brain injury. Transl Stroke Res 2017; 8: 560‒577.
  106. Zhou Y, Wang Y, Wang J, et al. Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation. Prog Neurobiol 2014; 115: 25‒44.
  107. Tan R, Traylor M, Rutten-Jacobs L, et al. New insights into mechanisms of small vessel disease stroke from genetics. Clin Sci (Lond) 2017; 131: 515‒531.
  108. Haffner C, Malik R, Dichgans M. Genetic factors in cerebral small vessel disease and their impact on stroke and dementia. J Cereb Blood Flow Metab 2016; 36: 158‒171.

 

Website by mzlaki logo Studio Mzlaki